Jessica Morgner

Jessica Morgner

Auto-generated profile, based on publicly available information

Jessica Morgner

Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 July 2021 in Nature Cell Biology
Verified
Journal Article
Closed access
PDF file
JKJanis Koester
Janis Koester
YMYekaterina A. Miroshnikova
Yekaterina A. Miroshnikova
SGSushmita Ghatak
Sushmita Ghatak
CCCarlos Andrés Chacón-Martínez
Carlos Andrés Chacón-Martínez
JMJessica Morgner
Jessica Morgner
SWSara A. Wickström
Sara A. Wickström

30 November 2020 in Life Science Alliance
Verified
Journal Article
Open access
PDF file
LBLaura Bornes
Laura Bornes
RWReinhard Windoffer
Reinhard Windoffer
Rudolf LeubeRudolf Leube
Rudolf Leube
JMJessica Morgner
Jessica Morgner
JRJacco Van Rheenen
Jacco Van Rheenen
Re-epithelialization is a crucial process to reestablish the protective barrier upon wounding of the skin. Although this process is well described for wounds where the complete epidermis and dermis is damaged, little is known about the re-epithelialization strategy in more frequently occurring smaller scratch wounds in which structures such as the hair follicles and sweat glands stay intact. To study this, we established a scratch wound model to follow individual keratinocytes in all epidermal layers in the back skin of mice by intravital microscopy. We discover that keratinocytes adopt a re-epithelialization strategy that enables them to bypass immobile obstacles such as hair follicles. Wound-induced cell loss is replenished by proliferation in a distinct zone away from the wound and this proliferation does not affect overall migration pattern. Whereas suprabasal keratinocytes are rather passive, basal keratinocytes move as a sheet of independently migrating cells into the wound, thereby constantly changing their direct neighboring cells enabling them to bypass intact obstacles. This re-epithelialization strategy results in a fast re-establishment of the protective skin barrier upon wounding.

1 November 2021 in Journal of Investigative Dermatology
Verified
Journal Article
Open access
RTRaneem Tayem
Raneem Tayem
CNCatherin Niemann
Catherin Niemann
MPMonika Pesch
Monika Pesch
JMJessica Morgner
Jessica Morgner
CNCarien M. Niessen
Carien M. Niessen
MAMonique Aumailley
Monique Aumailley
The skin epidermis is attached to the underlying dermis by a laminin 332 (Lm332)-rich basement membrane. Consequently, loss of Lm332 leads to the severe blistering disorder epidermolysis bullosa junctionalis in humans and animals. Owing to the indispensable role of Lm332 in keratinocyte adhesion in vivo, the severity of the disease has limited research into other functions of the protein. We have conditionally disrupted Lm332 expression in basal keratinocytes of adult mice. Although blisters develop along the interfollicular epidermis, hair follicle basal cells provide sufficient anchorage of the epidermis to the dermis, making inducible deletion of the Lama3 gene compatible with life. Loss of Lm332 promoted the thickening of the epidermis and exaggerated desquamation. Global RNA expression analysis revealed major changes in the expression of keratins, cornified envelope proteins, and cellular stress markers. These modifications of the keratinocyte genetic program are accompanied by changes in cell shape and disorganization of the actin cytoskeleton. These data indicate that loss of Lm332-mediated progenitor cell adhesion alters cell fate and disturbs epidermal homeostasis.

10 March 2023 in Developmental Cell
Verified
Journal Article
Open access
JMJessica Morgner
Jessica Morgner
LBLaura Bornes
Laura Bornes
KHKerstin Hahn
Kerstin Hahn
CLCarmen López-Iglesias
Carmen López-Iglesias
LKLona Kroese
Lona Kroese
JRJacco Van Rheenen
Jacco Van Rheenen
The basement membrane (BM) around tumor lobes forms a barrier to prevent cancer cells from invading the surrounding tissue. Although myoepithelial cells are key producers of the healthy mammary epithelium BM, they are nearly absent in mammary tumors. To study the origin and dynamics of the BM, we developed and imaged a laminin beta1-Dendra2 mouse model. We show that the turnover of laminin beta1 is faster in the BMs that surround the tumor lobes than in the BMs that surround the healthy epithelium. Moreover, we find that epithelial cancer cells and tumor-infiltrating endothelial cells synthesize laminin beta1 and that this production is temporarily and locally heterogeneous, leading to local discontinuity of the BM laminin beta1. Collectively, our data draw a new paradigm for tumor BM turnover in which the disassembly happens at a constant rate, and a local misbalance of compensating production leads to reduction or even complete disappearance of the BM.

30 April 2025 in Cancer Research
Verified
Journal Article
Closed access
CLCatrin Lutz
Catrin Lutz
XCXue Chao
Xue Chao
BKBim de Klein
Bim de Klein
JBJinhyuk Bhin
Jinhyuk Bhin
MBMadelon Badoux
Madelon Badoux
JJJos Jonkers
Jos Jonkers
Breast cancer is a heterogeneous disease with diverse morphologic and molecular subtypes. Preclinical models that recapitulate the heterogeneity of human breast cancer are needed to advance our fundamental understanding of what makes breast cancer an aggressive disease. To study mechanisms underlying breast cancer progression, we generated orthotopic cell line–derived xenograft (CDX) models from 20 different human breast cancer cell lines using both mammary intraductal injections and fat pad transplantations. The resulting mammary intraductal CDX and fat pad transplantation CDX models covered the full spectrum of disease progression, from in situ disease to metastatic growth. Pathologic analysis revealed two distinct tumor growth morphologies, flat versus nodular, and transcriptomic analysis identified the TGFβ pathway as a potential regulator of these two phenotypes in primary breast cancer. Indeed, knockout of SMAD4 converted nodular-growing tumors to a more confined disease, whereas constitutively active TGFβ receptor I renders lesions more aggressive. This research not only offers insights into the factors driving breast cancer morphology and aggressiveness but also establishes a comprehensive and valuable resource of well-characterized orthotopic CDX models for breast cancer research. Significance: Establishment and investigation of the largest collection of fully characterized breast cancer cell line xenograft models identifies key determinants of tumor morphology and aggressiveness and enables informed preclinical modeling for further research.